Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Orlistat Market Expected to Grow Between 2025 And 2029?

The orlistat industry has seen considerable growth in recent times. The market is predicted to rise from $3.03 billion in 2024 to $3.24 billion in 2025 with a compound annual growth rate (CAGR) of 6.7%. This growth in the mentioned period is due to increased awareness of obesity-related health dangers, authorization for use of orlistat as a prescribed medicine, the accessibility of orlistat in reduced doses over-the-counter, endorsements from physicians, and elevated healthcare costs associated with obesity.

What Growth Rate Is Anticipated for the Orlistat Market in the Coming Years?

The market size for orlistat is predicted to witness robust expansion in the forthcoming years. It is projected to reach $4.15 billion by 2029, with a compound annual growth rate (CAGR) of 6.4%. Several factors may contribute to this increase during the anticipated period, such as rising expenditure on healthcare for obesity treatments, inactive lifestyles coupled with poor dietary choices, government initiatives encouraging weight loss and healthy living, the growing number of older adults, and the transition from prescription drugs to over-the-counter medications. Noteworthy trends for the forecast period encompass AI-powered diet strategies, telemedicine services, mechanized devices that remind people to take their medicine and monitor adherence, virtual exercise routines, and digital therapeutics systems.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18422&type=smp

Who Are the Leading Companies in the Orlistat Market?

Major companies operating in the orlistat market are Merck & Co. Inc., Sanofi SA, GlaxoSmithKline plc, Roche Holding AG, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Intas Pharmaceuticals Ltd., Lupin Pharmaceuticals Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Zydus Life, Emcure Pharmaceuticals Ltd., Lannett Company Inc., Strides Pharma Science Ltd., Indoco Remedies Ltd., Wockhardt Ltd., Jubilant Life Sciences Ltd.

What Are the Key Drivers of the Orlistat Market?

The anticipated rise in obesity rates is projected to spur the expansion of the orlistat market. Obesity, which is defined as a medical condition where there is an excessive accumulation of body fat that could harm an individual’s health, is usually determined by a body mass index (BMI) of 30 or above. It is on the rise due to factors such as unhealthy diets, a dearth of physical exercise, and sedentary living habits. Orlistat plays a crucial role in the management of obesity as it prevents the absorption of dietary fats, thus aiding in weight reduction and maintaining lost weight. It is typically recommended in conjunction with a low-calorie diet and regular exercise for optimized outcomes. As per the World Health Organization (WHO), a Switzerland-based intergovernmental organization, in March 2022, obesity affected over 1 billion people worldwide, which included 650 million adults, 340 million adolescents, and 39 million children. This statistic is on an upward trajectory, and it is estimated that by 2025, approximately 167 million individuals, encompassing both adults and children, will suffer worsening health due to being overweight or obese. Hence, the escalating obesity rates are fueling the expansion of the orlistat market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=18422&type=smp

What Are the Key Market Segments in the Orlistat Industry?

The orlistat market covered in this report is segmented –

1) By Type: 120 Milligram (Mg), 60 Milligram(Mg)

2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

3) By Application: Weight-Reducing Aid, Other Applications

Subsegments:

1) By 120 Milligram (Mg): Prescription-Based 120 Mg Orlistat, Over-The-Counter (OTC) 120 Mg Orlistat

2) By 60 Milligram (Mg): Over-The-Counter (OTC) 60 Mg Orlistat, Prescription-Based 60 Mg Orlistat

What Are the Latest Trends in the Orlistat Market?

Leading firms in the orlistat market are spearheading the design of novel products, such as weight loss medications, leveraging advanced technology and design to augment personal hygiene and comfort. Weight loss medications are specially created to aid people in losing body weight by suppressing hunger, enhancing metabolism, or preventing fat absorption. For instance, Eli Lilly and Company, a pharmaceutical corporation based in the US, obtained approval from the US Food and Drug Administration (FDA) in November 2023 for Zepbound (tirzepatide) injection, which is a new weight loss medication. Zepbound stands as the only approved therapy that acts on two incretin hormone receptors, GIP and GLP-1, thus tackling a fundamental cause of weight gain. This drug is recommended for use in conjunction with a calorie-restricted diet and heightened physical activity for adults enduring chronic weight issues, specifically those with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) and presenting at least one weight-related health concern.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/orlistat-global-market-report

What Are the Key Regional Markets in the Orlistat Industry?

North America was the largest region in the orlistat market in 2023. The regions covered in the orlistat market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18422

This Report Delivers Insight On:

1. How big is the orlistat market, and how is it changing globally?

2. Who are the major companies in the orlistat market, and how are they performing?

3. What are the key opportunities and risks in the orlistat market right now?

4. Which products or customer segments are growing the most in the orlistat market?

5. What factors are helping or slowing down the growth of the orlistat market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model